UPDATE - Barclays Starts Sirius XM Radio (SIRI) at Underweight; Strong Growth Already Priced In
Get Alerts SIRI Hot Sheet
Price: $28.71 +1.13%
Rating Summary:
13 Buy, 12 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
13 Buy, 12 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
UPDATE - Barclays initiates coverage on Sirius XM Radio (NASDAQ: SIRI) with an Underweight. PT $2.00.
Analyst, James M. Ratcliffe, said, "We believe the SIRI business is healthy and expect material growth in EBITDA and FCF, but believe, at 14x 2013E EBITDA and nearly 19x 2013E fully-taxed FCF, growth is more than priced in at current levels."
Ratcliffe suggested investors consider 'Equalweight' rated Liberty Media (Nasdaq: LMCA), considering Liberty still holds a 40% stake in SIRI. However, a split off of that stake is expected in 2012. The Barclays analyst also feels that competition is strong (from internet based platforms, i.e. Pandora (NYSE: P)), but sees room for both to grow.
Note - Currently, shares of SIRI are trading at intraday low...last trade $2.1050, down 0.0450 (-2.09%).
Analyst, James M. Ratcliffe, said, "We believe the SIRI business is healthy and expect material growth in EBITDA and FCF, but believe, at 14x 2013E EBITDA and nearly 19x 2013E fully-taxed FCF, growth is more than priced in at current levels."
Ratcliffe suggested investors consider 'Equalweight' rated Liberty Media (Nasdaq: LMCA), considering Liberty still holds a 40% stake in SIRI. However, a split off of that stake is expected in 2012. The Barclays analyst also feels that competition is strong (from internet based platforms, i.e. Pandora (NYSE: P)), but sees room for both to grow.
Note - Currently, shares of SIRI are trading at intraday low...last trade $2.1050, down 0.0450 (-2.09%).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Needham Starts Faeth Therapeutics (FTH) at Buy
- Truist Securities Starts Matthews International (MATW) at Hold, 'We see risk/reward as more balanced'
- William Blair Starts Tandem Diabetes Care (TNDM) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share